The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic. Overcome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug. Discover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies. With 22+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges. Join us as we unite experts from across large pharma, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies. URLs: Tickets: https://go.evvnt.com/387645-0?pid=5569,Brochure: https://go.evvnt.com/387645-3?pid=5569 Prices:Standard Pricing: USD 2899.0,Earlybird Pricing: USD 2299.0 Speakers: Chad May, Maverick Therapeutics, David Poon, Zymeworks, Holger Wesche, Harpoon Therapeutics, Jessica Kirshner, Regeneron Pharmaceuticals, Michael Schmidt, Compass Therapeutics, Omid Vafa, TeneoBio, Pavel Pisa, Crescendo Biologics, Seung Chu, Xencor. Time: 9:00 am to 5:00 pm. Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States.